Jeffrey Garro
Stock Analyst at Stephens
(0.08)
# 4,755
Out of 5,060 analysts
70
Total ratings
31.3%
Success rate
-23%
Average return
Main Sectors:
Stocks Rated by Jeffrey Garro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OPRX OptimizeRx | Rated: Hold | $10 → $7 | $8.51 | -17.74% | 6 | May 13, 2026 | |
| CERT Certara | Reiterated: Buy | $12 → $9 | $9.37 | -3.95% | 6 | May 12, 2026 | |
| HCAT Health Catalyst | Reiterated: Hold | $2 → $1.75 | $1.73 | +1.45% | 5 | May 12, 2026 | |
| PHR Phreesia | Reiterated: Buy | $37 → $20 | $10.94 | +82.82% | 3 | Mar 31, 2026 | |
| DH Definitive Healthcare | Reiterated: Hold | $5 → $3 | $1.00 | +200.00% | 2 | Feb 27, 2026 | |
| EVH Evolent Health | Reiterated: Buy | $7 | $4.57 | +53.17% | 4 | Feb 25, 2026 | |
| TDOC Teladoc Health | Reiterated: Hold | $8 | $5.67 | n/a | 1 | Apr 30, 2025 | |
| PRVA Privia Health Group | Reiterated: Buy | $26 → $30 | $22.52 | n/a | 3 | Mar 5, 2025 | |
| MDRX Veradigm Inc. | Reiterated: Hold | $13 → $7 | $5.00 | n/a | 9 | Jan 31, 2025 | |
| DOCS Doximity | Initiated Coverage: Hold | $55 | $30.97 | n/a | 1 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $255 → $250 | $266.90 | n/a | 3 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $280 | $310.36 | n/a | 1 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $20 | $8.28 | n/a | 5 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $5 → $3.9 | $8.86 | n/a | 8 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $3 | $0.3242 | n/a | 7 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $128.23 | n/a | 1 | Dec 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | - | n/a | 5 | May 6, 2020 |
OptimizeRx
May 13, 2026
Rated: Hold
Price Target: $10 → $7
Current: $8.51
Upside: -17.74%
Certara
May 12, 2026
Reiterated: Buy
Price Target: $12 → $9
Current: $9.37
Upside: -3.95%
Health Catalyst
May 12, 2026
Reiterated: Hold
Price Target: $2 → $1.75
Current: $1.73
Upside: +1.45%
Phreesia
Mar 31, 2026
Reiterated: Buy
Price Target: $37 → $20
Current: $10.94
Upside: +82.82%
Definitive Healthcare
Feb 27, 2026
Reiterated: Hold
Price Target: $5 → $3
Current: $1.00
Upside: +200.00%
Evolent Health
Feb 25, 2026
Reiterated: Buy
Price Target: $7
Current: $4.57
Upside: +53.17%
Teladoc Health
Apr 30, 2025
Reiterated: Hold
Price Target: $8
Current: $5.67
Upside: n/a
Privia Health Group
Mar 5, 2025
Reiterated: Buy
Price Target: $26 → $30
Current: $22.52
Upside: n/a
Veradigm Inc.
Jan 31, 2025
Reiterated: Hold
Price Target: $13 → $7
Current: $5.00
Upside: n/a
Doximity
Dec 19, 2024
Initiated Coverage: Hold
Price Target: $55
Current: $30.97
Upside: n/a
Dec 19, 2024
Initiated Coverage: Buy
Price Target: $255 → $250
Current: $266.90
Upside: n/a
Dec 19, 2024
Initiated Coverage: Buy
Price Target: $280
Current: $310.36
Upside: n/a
Aug 5, 2022
Reiterated: Buy
Price Target: $15 → $20
Current: $8.28
Upside: n/a
May 11, 2022
Reiterated: Sell
Price Target: $5 → $3.9
Current: $8.86
Upside: n/a
May 5, 2022
Reiterated: Hold
Price Target: $4 → $3
Current: $0.3242
Upside: n/a
Dec 20, 2021
Reiterated: Buy
Price Target: n/a
Current: $128.23
Upside: n/a
May 6, 2020
Reiterated: Hold
Price Target: n/a
Current: -
Upside: n/a